MedTrace Logo

The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults

NCT04778371 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-12

No results posted yet for this study

Summary

The overall objective of this proposed randomized, crossover study is to determine the effect of 12 weeks of almond consumption, ingested as a snack twice daily, on energy expenditure, performance and functional related outcomes, in active, overweight, older adults, in comparison to 12 weeks of an isocaloric matched control snack. The central hypothesis of this study is, due to the nutritionally beneficial composition of almonds, that daily consumption of an almond snack for 12 weeks will contribute to improvements in energy expenditure, physical and functional performance, vascular function, inflammation/oxidative stress, sleep quality, mood status, and body composition in active, overweight and obese older adults compared to an isocaloric commercially available snack.

Conditions

Interventions

OTHER

Almonds

64 g total dry roasted, unsalted almonds per day for a total of 12 weeks

OTHER

Placebo

200 g total calorie matched granola bar per day for total of 12 weeks

Sponsors & Collaborators

  • Almond Board of California

    collaborator OTHER

  • Florida State University

    lead OTHER

Principal Investigators

  • Robert Hickner, PhD · Florida State University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-02
Primary Completion
2025-09-01
Completion
2026-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04778371 on ClinicalTrials.gov